Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. more
Time Frame | STAA | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.59% | -2.82% | 0.15% |
1-Month Return | -12.51% | -4.22% | 1.78% |
3-Month Return | -15.28% | -9.52% | 8.7% |
6-Month Return | -38.15% | -3.45% | 12.24% |
1-Year Return | -19.65% | 5.62% | 30.9% |
3-Year Return | -71.94% | 3.8% | 30.19% |
5-Year Return | -32.63% | 39.68% | 91.72% |
10-Year Return | 178.4% | 105.02% | 203.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 150.19M | 163.46M | 230.47M | 284.39M | 322.42M | [{"date":"2019-12-31","value":46.58,"profit":true},{"date":"2020-12-31","value":50.7,"profit":true},{"date":"2021-12-31","value":71.48,"profit":true},{"date":"2022-12-31","value":88.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 38.23M | 45.10M | 51.84M | 61.01M | 69.76M | [{"date":"2019-12-31","value":54.8,"profit":true},{"date":"2020-12-31","value":64.64,"profit":true},{"date":"2021-12-31","value":74.3,"profit":true},{"date":"2022-12-31","value":87.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 111.95M | 118.36M | 178.64M | 223.38M | 252.65M | [{"date":"2019-12-31","value":44.31,"profit":true},{"date":"2020-12-31","value":46.85,"profit":true},{"date":"2021-12-31","value":70.71,"profit":true},{"date":"2022-12-31","value":88.42,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 74.54% | 72.41% | 77.51% | 78.55% | 78.36% | [{"date":"2019-12-31","value":94.9,"profit":true},{"date":"2020-12-31","value":92.19,"profit":true},{"date":"2021-12-31","value":98.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.76,"profit":true}] |
Operating Expenses | 100.10M | 111.59M | 145.30M | 179.58M | 224.55M | [{"date":"2019-12-31","value":44.58,"profit":true},{"date":"2020-12-31","value":49.7,"profit":true},{"date":"2021-12-31","value":64.71,"profit":true},{"date":"2022-12-31","value":79.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 11.85M | 6.77M | 33.34M | 43.80M | 28.10M | [{"date":"2019-12-31","value":27.06,"profit":true},{"date":"2020-12-31","value":15.45,"profit":true},{"date":"2021-12-31","value":76.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.15,"profit":true}] |
Total Non-Operating Income/Expense | 2.16M | 1.74M | (2.07M) | 4.20M | 12.59M | [{"date":"2019-12-31","value":17.18,"profit":true},{"date":"2020-12-31","value":13.79,"profit":true},{"date":"2021-12-31","value":-16.47,"profit":false},{"date":"2022-12-31","value":33.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 13.03M | 8.27M | 31.30M | 45.80M | 33.70M | [{"date":"2019-12-31","value":28.44,"profit":true},{"date":"2020-12-31","value":18.05,"profit":true},{"date":"2021-12-31","value":68.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.57,"profit":true}] |
Income Taxes | (1.02M) | 2.35M | 6.80M | 6.80M | 12.35M | [{"date":"2019-12-31","value":-8.28,"profit":false},{"date":"2020-12-31","value":19.06,"profit":true},{"date":"2021-12-31","value":55.09,"profit":true},{"date":"2022-12-31","value":55.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 14.05M | 5.91M | 24.50M | 39.01M | 21.35M | [{"date":"2019-12-31","value":36.02,"profit":true},{"date":"2020-12-31","value":15.16,"profit":true},{"date":"2021-12-31","value":62.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.73,"profit":true}] |
Income From Continuous Operations | 14.05M | 5.91M | 24.50M | 39.01M | 21.35M | [{"date":"2019-12-31","value":36.02,"profit":true},{"date":"2020-12-31","value":15.16,"profit":true},{"date":"2021-12-31","value":62.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.73,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 14.05M | 5.91M | 27.51M | 39.66M | 21.35M | [{"date":"2019-12-31","value":35.42,"profit":true},{"date":"2020-12-31","value":14.91,"profit":true},{"date":"2021-12-31","value":69.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.82,"profit":true}] |
EPS (Diluted) | 0.47 | 0.35 | 0.87 | 1.06 | 0.92 | [{"date":"2019-12-31","value":44.34,"profit":true},{"date":"2020-12-31","value":33.02,"profit":true},{"date":"2021-12-31","value":82.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86.79,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
STAA | |
---|---|
Cash Ratio | 3.56 |
Current Ratio | 5.99 |
Quick Ratio | 5.38 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
STAA | |
---|---|
ROA (LTM) | 3.39% |
ROE (LTM) | 5.40% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
STAA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.20 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.80 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
STAA | |
---|---|
Trailing PE | 57.39 |
Forward PE | 196.08 |
P/S (TTM) | 3.65 |
P/B | 2.91 |
Price/FCF | NM |
EV/R | 3.07 |
EV/Ebitda | 33.35 |
PEG | NM |
STAAR Surgical Company (STAA) share price today is $25.39
Yes, Indians can buy shares of STAAR Surgical Company (STAA) on Vested. To buy STAAR Surgical Company from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in STAA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of STAAR Surgical Company (STAA) via the Vested app. You can start investing in STAAR Surgical Company (STAA) with a minimum investment of $1.
You can invest in shares of STAAR Surgical Company (STAA) via Vested in three simple steps:
The 52-week high price of STAAR Surgical Company (STAA) is $52.68. The 52-week low price of STAAR Surgical Company (STAA) is $25.04.
The price-to-earnings (P/E) ratio of STAAR Surgical Company (STAA) is 57.3864
The price-to-book (P/B) ratio of STAAR Surgical Company (STAA) is 2.91
The dividend yield of STAAR Surgical Company (STAA) is 0.00%
The market capitalization of STAAR Surgical Company (STAA) is $1.24B
The stock symbol (or ticker) of STAAR Surgical Company is STAA